Actuate Therapeutics Inc. (ACTU) Insider Trading
In the last 90 days, 1 Actuate Therapeutics Inc. (ACTU) insider reported 1 open-market purchase totaling $50,000 and no sales. The most recent open-market purchase was reported on Oct 28, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 1
- 90-day purchase value
- $50,000
- Corporate buyers
- 1
- Latest transaction
- Oct 28, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
ACTU insider trading FAQ
- Are ACTU insiders buying or selling?
- Over the last 90 days, ACTU insiders were net buyers, reporting $50,000 of open-market purchases and $0.00 of sales.
- When was the last ACTU insider purchase?
- The most recent open-market purchase of Actuate Therapeutics Inc. stock by an insider was reported on Oct 28, 2026, one of 1 purchase in the last 90 days.
- Where does ACTU insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Actuate Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp72 filings
- TWST insider tradingTwist Bioscience Corp30 filings
- NTRA insider tradingNatera Inc28 filings
- ARTV insider tradingArtiva Biotherapeutics Inc20 filings
- RVMD insider tradingRevolution Medicines Inc20 filings
- TEM insider tradingTempus AI Inc20 filings
- CSTL insider tradingCastle Biosciences Inc19 filings
- PACS insider tradingPACS Group Inc.19 filings
